Literature DB >> 66910

Experimentally induced bleomycin sulfate pulmonary toxicity: histopathologic and ultrastructural study in the pheasant.

C W Bedrossian, S D Greenberg, D H Yawn, R M O'Neal.   

Abstract

Morphological alterations in the lungs of pheasants after prolonged high-dosage administration of bleomycin sulfate were studied by light and electron microscopy. Nontreated birds acted as controls, and their lungs showed no abnormalities. Lungs of bleomycin-treated pheasants revealed collapse alternating with overexpansion, marked cuboidalization of atrial epithelium, and incipient interstitial fibrosis. There were neither lymphoplasmacytic or eosinophilic infiltrates, nor evidence of vasculitis. Ultrastructurally, type 1 alveolar epithelial cells were either reactive or conspicuously absent in the air capillaries. Type 2 alveolar epithelial cells appeared hyperplastic with numerous lamellar bodies, many of which extruded into air spaces. Immature fibroblasts were noted in the vicinity of collagen fibrils or amorphous material resembling elastin. No immune deposits were present in basement membranes. These findings are consistent with a direct toxic effect of bleomycin to the pheasant lung rather than a drug hypersensitivity reaction. Reproduction of the bleomycin lesion in a nonmammalian species corroborates even further the high propensity of the drug to affect the lung.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66910

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

Review 1.  Lung damage from cytotoxic drugs.

Authors:  C H Collis
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  Bleomycin-induced lung injury in baboons: alteration of cells and immunoglobulins recoverable by bronchoalveolar lavage.

Authors:  B McCullough; S Schneider; N D Greene; W G Johanson
Journal:  Lung       Date:  1978       Impact factor: 2.584

3.  Chronic airway obstruction and bronchiectasis in the rat after intratracheal bleomycin.

Authors:  D L Costa; J R Lehmann; D N Slatkin; E A Popenoe; R T Drew
Journal:  Lung       Date:  1983       Impact factor: 2.584

4.  Inhibition of bleomycin-induced pulmonary fibrosis by cobra venom factor.

Authors:  S H Phan; R S Thrall
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

5.  The role of soluble factors in bleomycin-induced pulmonary fibrosis.

Authors:  S H Phan; R S Thrall
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.